X-ZELL Blog Episode 12

Episode 12 Why building on tradition is key to a future without cancer Two years ago, almost to the day, X-ZELL hit a milestone that many say separates the wheat from the chaff – the equally daunting and exhilarating leap from research to commercialisation. Under the...

X-ZELL Blog Episode 11

Episode 11 Why Singapore is Asia’s leading med tech hub Artificial intelligence, 3D printing, driverless transportation – the innovation wheel has never spun as fast as today. Despite the much-cited Theranos effect – coined by Bloomberg to describe the painful...

X-ZELL Blog Episode 10

Episode 10 Think macro, act micro Less than two years after starting the transition from local research company into global enterprise, X-ZELL is about to celebrate our biggest milestone yet – the long-anticipated world premiere of the X-ZELL Cryoimmunostaining™...

X-ZELL Blog Episode 9

Episode 9 Why prostate cancer screening is back on the agenda Largely unnoticed by the general public, early prostate cancer detection recently rose to the very top of the European Parliament’s teeming agenda. Coinciding with the European Prostate Cancer Awareness Day...

X-ZELL Blog Episode 8

Episode 8 MRI before biopsy? In episode five of the new X-ZELL blog, our editorial team first shed a light on the growing controversy around the utility of multi-parametric magnetic resonance imaging (mpMRI) as a triage test to avoid unnecessary biopsy and improve...

X-ZELL Blog Episode 7

Episode 7 CEC research gaining global recognition Less than three months ago, in August 2018, X-ZELL CEO Dr Sebastian Bhakdi took to stage at the 19th Asia-Pacific Prostate Cancer Conference in Brisbane (Australia) to reveal an unexpected breakthrough in early cancer...